CLASS A COMMON STOCK PURCHASE WARRANTWarrant Agreement • May 15th, 2024 • Bioquest Corp • Pharmaceutical preparations • Nevada
Contract Type FiledMay 15th, 2024 Company Industry JurisdictionTHIS CLASS A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ______________ (the “Initial Issue Date”) and on or prior to the close of business on the two (2) year anniversary of the Initial Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioQuest Corp., a Nevada corporation (the “Company”), up to ___________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
BIOQUEST CORP. SUBSCRIPTION AGREEMENTSubscription Agreement • May 15th, 2024 • Bioquest Corp • Pharmaceutical preparations • Nevada
Contract Type FiledMay 15th, 2024 Company Industry JurisdictionTHIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
March 21, 2024 BotMakers AI, Inc. 6725 South Fry Katy, Texas 77494 To whom:Merger Agreement • May 15th, 2024 • Bioquest Corp • Pharmaceutical preparations
Contract Type FiledMay 15th, 2024 Company IndustryThis letter is intended to express the general terms of the Plan of Acquisition to be formalized between BioQuest Corp., a Nevada corporation (“BioQuest” “Company”) and BotMakers AI, Inc., Delaware Corporation, (“BOTMAKERS AI, INC. “). The objective of our discussions has been the execution and consummation, as soon as feasible, of a formal Agreement between BioQuest and BOTMAKERS AI, INC. and its Shareholders (the “Exchange Agreement”) which, among other things, would provide for the various matters set forth below.